Management of paediatric thyroid carcinoma: Recent experience with recombinant human thyroid stimulating hormone in preparation for radioiodine therapy

Internal Medicine Journal

Volumn 36, Issue 9, 2006, Pages 564-570

  Lau, W F E ^a   Zacharin, M R ^a,b   Waters, K ^b   Wheeler, G ^a   Johnston, V ^a   Hicks, R J ^a  

^a PETER MACCALLUM CANCER CENTRE   (Australia)

^b ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Paediatric; Radiation; Radioiodine; Recombinant human thyroid stimulating hormone; Thyroid cancer

Indexed keywords

IODINE; RADIOACTIVE IODINE; RECOMBINANT HORMONE; THYROTROPIN; THYROXINE;

ADOLESCENT; ARTICLE; CHILDHOOD CANCER; CLINICAL ARTICLE; CONTROLLED STUDY; EXPERIENCE; FEMALE; FOLLICULAR CARCINOMA; HORMONAL REGULATION; HORMONE SUBSTITUTION; HOSPITAL PATIENT; HUMAN; IRRADIATION; LUNG METASTASIS; LYMPH NODE METASTASIS; MALE; NAUSEA AND VOMITING; NUCLEAR MEDICINE; PAPILLARY CARCINOMA; PRESCHOOL CHILD; PRIORITY JOURNAL; RADIATION DOSE; SCHOOL CHILD; STATISTICAL ANALYSIS; THYROID CARCINOMA; THYROIDECTOMY; UNSPECIFIED SIDE EFFECT;

ADOLESCENT; CHILD; CHILD, PRESCHOOL; DISEASE MANAGEMENT; FEMALE; HUMANS; IODINE RADIOISOTOPES; MALE; THYROID NEOPLASMS; THYROTROPIN;

EID: 33746788173     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2006.01149.x     Document Type: Article

References (25)

1. The Cancer Council Victoria Epidemiology Centre. Cancer Survival in Victoria - Relative Survival for Thyroid Cancer. Melbourne, Victoria: Cancer Council Victoria; 2003; 60-61.
2. Samuel AM, Sharma SM. Differentiated thyroid carcinomas in children and adolescents. Cancer 1991; 67: 2186-90.
3. Dottorini ME, Vignati A, Mazzucchelli L, Lomuscio G, Colombo L. Differentiated thyroid carcinoma in children and adolescents: a 37-year experience in 85 patients. J Nucl Med 1997; 38: 669-75.
4. Jarzab B, Junak DH, Wloch J, Kalemba B, Roskosz J, Kukulska A et al. Multivariate analysis of prognostic factors for differentiated thyroid carcinoma in children. Eur J Nucl Med Mol Imag 2000; 27: 833-41.
5. Haveman JW, Van Tol KM, Rouwe CW, Piers DA, Plukker JTM. Surgical experience in children with differentiated thyroid carcinoma. Ann Surg Oncol 2003; 10: 15-20.
6. Kowalski LP, Filho JG, Pinto CAL, Carvalho AL, De Camargo B. Long term survival in young patients with thyroid carcinoma. Arch Otolaryngol Head Neck Surg 2003; 129: 746-9.
7. Ceccarelli C, Pacini F, Lippi F, Elisei R, Arganini M, Miccoli P et al. Thyroid cancer in children and adolescents. Surgery 1988; 104: 1143-8.
8. Hod N, Hagag P, Baumer M, Sandbank J, Horne T. Differentiated thyroid carcinoma in children and young adults: evaluation of response to treatment. Clin Nucl Med 2005; 30: 387-90.
9. Hameed R and Zacharin M. The changing face of thyroid cancer in children and adolescents. J Paediatr Child Health 2005; 41: 572-4.
10. Robbins RJ, Schlumberger MJ. The evolving role of I-131 for the treatment of differentiated thyroid carcinoma. J Nucl Med 2005; 46: 28S-37S.
11. Hung W, Sarlis NJ. Current controversies in the management of pediatric patients with well differentiated non-medullary thyroid cancer: a review. Thyroid 2002; 12: 683-702.
12. Vassilopoulou-Sellin R, Klein MJ, Smith TH, Samaan NA, Frankenthaler RA, Goepfert H et al. Pulmonary metastases in children and young adults with differentiated thyroid cancer. Cancer 1993; 71: 1348-52.
13. Siddiqi A, Foley RR, Britton KE, Sibtain A, Plowman PN, Grossman AB et al. The role of I-123 diagnostic imaging in the follow up with differentiated thyroid carcinoma as compared to I-13 scanning: avoidance of negative therapeutic uptake due to stunning. Clin Endocrinol 2001; 55: 515-21.
14. Alzahrani AS, Bakheet S, Mandil MA, Al-Hajjaj A, Almahfouz A, Al Haq A. I-123 isotope as a diagnostic agent in the follow up of patients with differentiated thyroid cancer: comparison with post I-131 therapy whole body scanning. J Clin Endocrinol Metab 2001; 86: 5294-300.
15. Yaakob W, Gordon L, Spicer KM, Nitke SJ. The usefulness of iodine-123whole body scans in evaluating thyroid carcinoma and metastases. J Nucl Med Technol 1999; 27: 279-81.
16. Pacini F. Follow up of differentiated thyroid cancer. Eur J Nucl Med 2002; 29 (Suppl. 2): S492-S496.
17. Robbins RJ, Tuttle RM, Sharaf RN, Larson SM, Robbins HK, Ghossein RA et al. Preparation by recombinant human thyrotropin or thyroid hormone withdrawal are comparable for the detection of residual differentiated thyroid carcinoma. J Clin Endocrinol Metab 2001; 86: 619-25.
18. Robbins RJ, Tuttle RM, Sonenberg M, Shaha A, Sharaf R, Robbins H et al. Radioiodine ablation of thyroid remnants after preparation with recombinant human thyrotropin. Thyroid 2001; 11: 865-9.
19. Robbins RJ, Larson SM, Sinha N, Shaha A, Divgi C, Pentlow K et al. A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation. J Nucl Med 2002; 43: 1482-8.
20. Luster M, Lassmann M, Haenscheid H, Michalowski U, Incerti C, Reiners C. Use of recombinant human thyrotropin before radioiodine therapy in patients with advanced differentiated thyroid carcinoma. J Clin Endocrinol Metab 2000; 85: 3640-45.
21. Menzel C, Kranert WT, Dobert N, Diehl M, Fietz T, Hamscho N et al. rhTSH stimulation before radioiodine therapy in thyroid cancer reduces the effective half-life of I-131. J Nucl Med 2003; 44: 1065-8.
22. Pacini F, Molinaro E, Castagna MG, Lippi F, Ceccarelli C, Agate L et al. Ablation of thyroid residues with 30mCi I-131: a comparison in thyroid cancer patients prepared with recombinant human TSH or thyroid hormone withdrawal. J Clin Endocrinol Metab 2002; 87: 4063-8.
23. Robbins RJ, Pentlow KS. Coming of age- recombinant human thyroid stimulating hormone as a preparation for I-131 therapy in thyroid cancer. J Nucl Med 2003; 44: 1069-71.
24. Barbaro D, Boni G, Meucci G, Simi U, Lapi P, Orsini P et al. Radioiodine treatment with 30mCi after recombinant human thyrotropin stimulation in thyroid cancer: effectiveness for post-surgical remnants ablation and possible role of iodine content in L-thyroxine in the outcome of ablation. J Clin Endocrinol Metab 2003; 88: 4110-15.
25. Sherman SI. Thyroid carcinoma. Lancet 2003; 361: 501-11.